NovaPoint Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,368
| Closed | -$1.18M | – | 123 |
|
|
2025
Q1 | $1.18M | Sell |
2,368
-113
| -5% | -$56.2K | 0.36% | 64 |
|
|
2024
Q4 | $1.29M | Buy |
2,481
+12
| +0.5% | +$6.24K | 0.39% | 61 |
|
|
2024
Q3 | $1.53M | Buy |
2,469
+14
| +0.6% | +$8.66K | 0.47% | 58 |
|
|
2024
Q2 | $1.36M | Buy |
2,455
+17
| +0.7% | +$9.4K | 0.46% | 61 |
|
|
2024
Q1 | $1.42M | Buy |
2,438
+315
| +15% | +$183K | 0.5% | 61 |
|
|
2023
Q4 | $1.13M | Sell |
2,123
-44
| -2% | -$23.4K | 0.42% | 61 |
|
|
2023
Q3 | $1.1M | Buy |
2,167
+15
| +0.7% | +$7.59K | 0.44% | 59 |
|
|
2023
Q2 | $1.12M | Sell |
2,152
-2
| -0.1% | -$1.04K | 0.42% | 60 |
|
|
2023
Q1 | $1.24M | Buy |
2,154
+2
| +0.1% | +$1.15K | 0.51% | 54 |
|
|
2022
Q4 | $1.19M | Sell |
2,152
-32
| -1% | -$17.6K | 0.52% | 52 |
|
|
2022
Q3 | $1.11M | Sell |
2,184
-103
| -5% | -$52.3K | 0.5% | 57 |
|
|
2022
Q2 | $1.24M | Sell |
2,287
-55
| -2% | -$29.9K | 0.54% | 59 |
|
|
2022
Q1 | $1.38M | Sell |
2,342
-13
| -0.6% | -$7.68K | 0.5% | 62 |
|
|
2021
Q4 | $1.57M | Buy |
2,355
+272
| +13% | +$181K | 0.56% | 59 |
|
|
2021
Q3 | $1.19M | Buy |
2,083
+853
| +69% | +$487K | 0.48% | 61 |
|
|
2021
Q2 | $620K | Hold |
1,230
| – | – | 0.26% | 71 |
|
|
2021
Q1 | $561K | Buy |
1,230
+95
| +8% | +$43.3K | 0.26% | 71 |
|
|
2020
Q4 | $529K | Buy |
1,135
+630
| +125% | +$294K | 0.28% | 70 |
|
|
2020
Q3 | $223K | Buy |
+505
| New | +$223K | 0.14% | 93 |
|